PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B
Tóm tắt
Plexin-domain containing 2 (PLXDC2) has been reported as an oncoprotein in several human malignancies. However, its expression and roles in gastric cancer remain largely unclear. In this study, we found that PLXDC2 was highly expressed in gastric cancer tissues, and the expression levels were positively correlated with clinicopathological features, but negatively with the patients’ outcome. Cox regression analysis identified PLXDC2 as an independent prognostic indicator for the patients. Knockdown of PLXDC2 markedly suppressed the in vitro invasion and in vivo metastasis of gastric cancer cells, while overexpression of PLXDC2 resulted in opposite effects. Mechanistically, PLXDC2 enhanced the level of phosphorylated Cortactin (p-Cortactin) by physically interacting with protein tyrosine phosphatase 1B (PTP1B), an important dephosphorylase, to prevent its dephosphorylating of p-Cortactin, thereby promoting the formation of invadopodia. Collectively, our results indicate that PLXDC2 contributes to the invasion and metastasis of gastric cancer by inhibiting PTP1B to facilitate the invadopodium formation, and may serve as a potential prognostic biomarker and a therapeutic target for this disease.
Từ khóa
Tài liệu tham khảo
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654
Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou XN, Chen R et al (2019) Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi 41:19–28. https://doi.org/10.3760/cma.j.issn.0253-3766.2019.01.005
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer. Lancet 388:2654–2664. https://doi.org/10.1016/S0140-6736(16)30354-3
Harada K, Lopez A, Shanbhag N, Badgwell B, Baba H, Ajani J (2018) Recent advances in the management of gastric adenocarcinoma patients. F1000Res. https://doi.org/10.12688/f1000research.15133.1
Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P et al (2001) Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410:174–179. https://doi.org/10.1038/35065539
St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E et al (2000) Genes expressed in human tumor endothelium. Science 289:1197–1202. https://doi.org/10.1126/science.289.5482.1197
Miller-Delaney SF, Lieberam I, Murphy P, Mitchell KJ (2011) Plxdc2 is a mitogen for neural progenitors. PLoS ONE 6:e14565. https://doi.org/10.1371/journal.pone.0014565
Cheng G, Zhong M, Kawaguchi R, Kassai M, Al-Ubaidi M, Deng J et al (2014) Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF. Elife 3:e05401. https://doi.org/10.7554/eLife.05401
Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG (2004) Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 21:31–37. https://doi.org/10.1023/b:clin.0000017168.83616.d0
Yamamoto N, Eguchi A, Hirokawa Y, Ogura S, Sugimoto K, Iwasa M et al (2020) Expression pattern of plexin domain containing 2 in human hepatocellular carcinoma. Monoclon Antib Immunodiagn Immunother 39:57–60. https://doi.org/10.1089/mab.2019.0050
Lavorato-Rocha AM, Akagi EM, de Melo MB, Rodrigues IS, Botelho MC, Marchi FA et al (2016) An integrative approach uncovers biomarkers that associate with clinically relevant disease outcomes in vulvar carcinoma. Mol Cancer Res 14:720–729. https://doi.org/10.1158/1541-7786.MCR-15-0366
Wang Y, Li H (2018) Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics. Oncol Lett 15:9793–9801. https://doi.org/10.3892/ol.2018.8600
Guan Y, Du Y, Wang G, Gou H, Xue Y, Xu J et al (2021) Overexpression of PLXDC2 in stromal cell-associated M2 macrophages is related to EMT and the progression of gastric cancer. Front Cell Dev Biol 9:673295. https://doi.org/10.3389/fcell.2021.673295
Davis S, Meltzer PS (2007) GEOquery: a bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics 23:1846–1847
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3
Chen M, Yu X, Xu J, Ma J, Chen X, Chen B et al (2019) Association of gene polymorphisms with primary open angle glaucoma: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci 60:1105–1121. https://doi.org/10.1167/iovs.18-25922
Bao G, Wang N, Li R, Xu G, Liu P, He B (2016) Glycoprotein non-metastaticmelanoma protein B promotes glioma motility and angiogenesis through the Wnt/beta-catenin signaling pathway. Exp Biol Med (Maywood) 241:1968–1976. https://doi.org/10.1177/1535370216654224
Ji CD, Wang YX, Xiang DF, Liu Q, Zhou ZH, Qian F et al (2018) Kir2.1 interaction with Stk38 promotes invasion and metastasis of human gastric cancer by enhancing MEKK2-MEK1/2-ERK1/2 signaling. Cancer Res 78:3041–3053. https://doi.org/10.1158/0008-5472.CAN-17-3776
Ali A, Soares AB, Eymael D, Magalhaes M (2021) Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation. J Pathol Clin Res 7:61–74. https://doi.org/10.1002/cjp2.182
Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213–232. https://doi.org/10.1111/j.1365-2818.2006.01706.x
Buccione R, Caldieri G, Ayala I (2009) Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 28:137–149. https://doi.org/10.1007/s10555-008-9176-1
Weaver AM (2006) Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 23:97–105. https://doi.org/10.1007/s10585-006-9014-1
Eddy RJ, Weidmann MD, Sharma VP, Condeelis JS (2017) Tumor cell invadopodia: invasive protrusions that orchestrate metastasis. Trends Cell Biol 27:595–607. https://doi.org/10.1016/j.tcb.2017.03.003
Jeannot P, Besson A (2020) Cortactin function in invadopodia. Small GTPases 11:256–270. https://doi.org/10.1080/21541248.2017.1405773
Castro-Castro A, Marchesin V, Monteiro P, Lodillinsky C, Rosse C, Chavrier P (2016) Cellular and molecular mechanisms of MT1-MMP-dependent cancer cell invasion. Annu Rev Cell Dev Biol 32:555–576. https://doi.org/10.1146/annurev-cellbio-111315-125227
Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA et al (2000) Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol 151:29–40. https://doi.org/10.1083/jcb.151.1.29
Stuible M, Dube N, Tremblay ML (2008) PTP1B regulates cortactin tyrosine phosphorylation by targeting Tyr446. J Biol Chem 283:15740–15746. https://doi.org/10.1074/jbc.M710534200
Mertins P, Eberl HC, Renkawitz J, Olsen JV, Tremblay ML, Mann M et al (2008) Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Mol Cell Proteomics 7:1763–1777. https://doi.org/10.1074/mcp.M800196-MCP200
Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359:2814–2823. https://doi.org/10.1056/NEJMra0805239
Saykali BA, El-Sibai M (2014) Invadopodia, regulation, and assembly in cancer cell invasion. Cell Commun Adhes 21:207–212. https://doi.org/10.3109/15419061.2014.923845
From the American Association of Neurological Surgeons ASoNC, Interventional Radiology Society of Europe CIRACoNSESoMINTESoNESOSfCA, Interventions SoIRSoNS, World Stroke O, Sacks D, Baxter B et al (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612–632. https://doi.org/10.1177/1747493018778713
Hamad HA, Enezei HH, Alrawas A, Zakuan NM, Abdullah NA, Cheah YK et al (2020) Identification of potential chemical substrates as fuel for hypoxic tumors that may be linked to invadopodium formation in hypoxia-induced MDA-MB-231 breast-cancer cell line. Molecules. https://doi.org/10.3390/molecules25173876
Chen L, Zhu M, Yu S, Hai L, Zhang L, Zhang C et al (2020) Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells. Exp Cell Res 389:111893. https://doi.org/10.1016/j.yexcr.2020.111893
Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H et al (2019) Aspartate beta-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol 12:144. https://doi.org/10.1186/s13045-019-0837-z
Li Y, Zhang H, Gong H, Yuan Y, Li Y, Wang C et al (2018) miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene. J Exp Clin Cancer Res 37:141. https://doi.org/10.1186/s13046-018-0824-1
Ke Y, Bao T, Zhou Q, Wang Y, Ge J, Fu B et al (2017) Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5. Int J Cancer 141:364–376. https://doi.org/10.1002/ijc.30730
Rajadurai CV, Havrylov S, Zaoui K, Vaillancourt R, Stuible M, Naujokas M et al (2012) Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia. J Cell Sci 125:2940–2953. https://doi.org/10.1242/jcs.100834
Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ et al (2010) Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J Cell Sci 123:3662–3673. https://doi.org/10.1242/jcs.068163
Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS (2004) Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 24:5269–5280. https://doi.org/10.1128/MCB.24.12.5269-5280.2004
Lua BL, andLow BC. (2005) Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 579:577–585. https://doi.org/10.1016/j.febslet.2004.12.055
Weidmann MD, Surve CR, Eddy RJ, Chen X, Gertler FB, Sharma VP et al (2016) Mena(INV) dysregulates cortactin phosphorylation to promote invadopodium maturation. Sci Rep 6:36142. https://doi.org/10.1038/srep36142
Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66:3034–3043. https://doi.org/10.1158/0008-5472.CAN-05-2177
Clark ES, Whigham AS, Yarbrough WG, Weaver AM (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67:4227–4235. https://doi.org/10.1158/0008-5472.CAN-06-3928
Kelley LC, Hayes KE, Ammer AG, Martin KH, Weed SA (2010) Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS ONE 5:e13847. https://doi.org/10.1371/journal.pone.0013847
Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X et al (2009) Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol 186:571–587. https://doi.org/10.1083/jcb.200812176
Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, Woodrow M et al (2005) The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 7:155–165. https://doi.org/10.1016/j.ccr.2005.01.006
Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, Roth TM et al (2003) The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem 278:16844–16851. https://doi.org/10.1074/jbc.M300267200
Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA (2009) The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell 20:1302–1311. https://doi.org/10.1091/mbc.E08-09-0949
Yu X, Zech T, McDonald L, Gonzalez EG, Li A, Macpherson I et al (2012) N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopods. J Cell Biol 199:527–544. https://doi.org/10.1083/jcb.201203025